Company news

Avenir Wellness Solutions Inc. (OTC:AVRW) news

Avenir Wellness Solutions Inc. news releases on 6ix. Latest, Dec 16, 2024: Avenir Wellness Solutions Announces Global Settlement with Ionic Ventures…

View Avenir Wellness Solutions Inc. →

Press releases & updates

Avenir Wellness Solutions Announces Global Settlement with Ionic Ventures, Eliminating Convertible Debt

December 15, 2024

Avenir Wellness Solutions Reports Fourth Quarter 2023 Results

May 16, 2024

Avenir Wellness Solutions Issues 2024 Marketing Growth Plans to Shareholders for Seratopical Revolution Skin Care Line with Support from Nicole Kidman and Facial Plastic Surgeon Dr. Michael Persky

February 12, 2024

Avenir Wellness Solutions Announces Return of Stock Trading Back to OTCQB Market

September 18, 2023

OTC Markets Group Welcomes New OTCQB Companies – September 18

September 18, 2023

The Sera Labs, Inc. Announces Partnership With LA-Based Facial Plastic Surgeon Dr. Michael Persky to Support Latest DNA Complex Product Launch

September 11, 2023

Avenir Wellness Solutions Reports Second Quarter 2023 Results

August 14, 2023

Avenir Wellness Solutions Announces New Ticker Symbol As Final Part of Exciting New Brand Identity

August 7, 2023

Avenir Wellness Solutions Reports First Quarter 2023 Results with Strong Sequential and Year Over Year Revenue Increases and Continued High Gross Margins

July 30, 2023

New to The Street Announces the Televised Lineups for Shows 481, 482, and 483; Airings on Three Networks Will Begin on Saturday, June 24, 2023, at 3:30 PM ET

June 22, 2023

New to The Street Announces TV Corporate Appearances on Episodes 479 and 480 that Start Airing on Saturday, June 17, 2023, at 3:30 PM ET

June 15, 2023

Avenir Wellness Solutions Update to Stockholders

May 16, 2023

New to The Street Announces the Televised Lineups for Shows 461, 462, and 463; Airings on Three Networks Will Begin on Saturday, April 29, 2023, at 3:30 PM ET

April 27, 2023

Avenir Wellness Solutions (OTCQB:CURR) to Present at the Planet MicroCap Showcase - Live Webcast Available

April 25, 2023

Avenir Wellness Letter to Stockholders

April 24, 2023

New to The Street Announces the Televised Lineups for Shows 452, 457, and 458, Airings on Three Networks Will Begin Tonight, Thursday, April 13, 2023, at 9:30 PM ET

April 12, 2023

New to The Street Announces Corporate Guests Appearances for Airings on TV Episodes 454 and 455 Starting Saturday, April 1, 2023, at 3:30 PM ET

March 30, 2023

New to The Street Announces the Televised Lineups for Shows 451, 452, and 453; Airings on Three Networks Will Begin on Saturday, March 25, 2023, at 3:30 PM ET

March 23, 2023

Avenir's Sera Labs Launches Patent Pending DNA Complex with Advanced Peptides and Compounds - Providing Instant and Long-Lasting Results With Daily Use

March 15, 2023

New to The Street Announces the Televised Lineups for Shows 441, 442, and 443, Airings on Three Networks Will Begin on Saturday, February 25, 2023, 3:30 PM ET

February 24, 2023

Avenir Wellness Solutions, Inc. Gains High Profile Exposure on theSkimm Social Media Platform With 7 Million Followers and Launches New Website in Support of Corporate Rebranding

February 12, 2023

New to The Street TV Announces Episode #435 with its Five Business Guest Interviews, Airs as Sponsored Programming on Bloomberg TV, Tonight, February 9, 2023, at 9:30 PM PT

February 9, 2023

New to The Street Announces Episode #435, Interviews with Five Corporate Executives, Airing on the Fox Business Network, Tonight, Monday, February 6, 2023, at 10:30 PM PT

February 6, 2023

New to The Street TV / Newsmax TV Announces Five Corporate Interviews Episode #434 Airing Saturday, February 4, 2023, 3:30 PM ET

February 3, 2023

Avenir Wellness Solutions to Launch Wall Street-focused Informational Series with Producer New to The Street

January 18, 2023

CURE Pharmaceutical Unveils Exciting New Brand Identity with Name Change to Avenir Wellness Solutions, Inc.

January 16, 2023

CURE Pharmaceutical Letter to Shareholders

December 14, 2022

CURE Pharmaceutical Reports Third Quarter 2022 Results With Strong Sequential and Year Over Year Revenue Increases and Continued High Margins

November 21, 2022

Cure Pharmaceutical Reports Second Quarter 2022 Results With Increased Sequential Revenues and Strong Margins

September 2, 2022

CURE Pharmaceutical Announces Rob Davidson as new Chairman of the Board and Appointment of Rob Costantino as Member of the Board and Audit Committee Chairman

August 16, 2022

CURE Pharmaceutical Provided Full Corporate Update on Recent Shareholder Call

August 9, 2022

CURE Pharmaceutical Announces the Appointment of New Board Member

August 2, 2022

CURE Pharmaceutical Announces Teleconference With Investors

August 1, 2022

CURE Pharmaceutical Announces the Sale of a Portion of its Platform Technology IP for $20 Million

July 28, 2022

CURE Pharmaceutical Announces Positive Findings from Study at Cincinnati Children’s Hospital Medical Center (CCHMC) Using CURE’s Proprietary, Oral Thin Film (OTF) High, Single Dose Vitamin D in Pediatric Patients Pre- and Post-Hematopoietic St

May 12, 2022

Keynotes, Educational Panels and 88 Companies to Present at the Planet MicroCap Showcase on May 3-5, 2022 at Bally's Hotel & Casino in Las Vegas, NV

April 26, 2022

Sera Labs Inc. Products Now Available at Walmart, Bed Bath & Beyond, CVS and Target.com

April 14, 2022

CURE Pharmaceutical and Milagro Pharmaceuticals Collaborate for Registration and Approval to Sell Sildenafil Oral Thin Film in Mexico

March 3, 2022

Sera Labs, a Subsidiary of CURE Pharmaceutical, Consummates Exclusive International Distribution Agreement With Leading Canadian Distributor

December 9, 2021

CURE Pharmaceutical Receives Patent Approval for Its CUREfilm Blue™ Technology

November 16, 2021

CURE Pharmaceutical Reports Second Quarter 2021 Revenue Rose Nearly 700% Driven by Sales from Sera Labs Product Lines

August 17, 2021

Keynotes, Educational Panels and 60 Companies to Present at the SNN Network Summer Virtual Event on August 17-19, 2021

August 15, 2021

Seratopical Revolution Skincare Line by The Sera Labs Inc., a CURE Pharmaceutical Company, will be Available for Purchase this Fall at CVS, one of the Leading National Drug Store Chains

August 4, 2021

CURE Pharmaceutical to Present at H.C. Wainwright 2021 Psychedelics in Psychiatry and Beyond Virtual Conference

June 15, 2021

CURE Pharmaceutical Signs Agreement to Develop CBD and THC Oral Thin Films and Conduct Clinical Studies Targeting Veteran Health

June 10, 2021

Nicole Kidman and Sera Labs Inc., a CURE Pharmaceutical Company, Launch Seratopical Revolution and New Ad Campaign

June 9, 2021

CURE Pharmaceutical Schedules Investor Webcast for Thursday, May 27, 2021

May 25, 2021

CURE Pharmaceutical First Quarter Revenue Quadruples to $1.5 million; Company Expands Clinical Pipeline to Include Psychedelics

May 17, 2021

CURE Pharmaceutical Receives ISO Certification for Laboratory and Manufacturing Facility

May 13, 2021

Nicole Kidman, Sera Labs Strategic Business Partner/Global Brand Ambassador and Nancy Duitch, Sera Labs Founder/CEO Headline Collision 2021 and Talk the Future of Beauty Technology

April 28, 2021

Older →